Global Parkinson's Disease Drugs Market Share

Statistics for the 2023 & 2024 Global Parkinson's Disease Drugs market share, created by Mordor Intelligence™ Industry Reports. Global Parkinson's Disease Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Parkinson's Disease Drugs Industry

The Parkinson's disease drugs market is becoming highly competitive. The recent product launches and the high number of therapeutics in product pipelines of the global pharmaceutical firms are contributing to the dynamic nature of the market. Several new products are expected to be launched during the forecast period, which may lead to significant changes in the market shares of pharmaceutical firms that are currently active in the market. Amneal Pharmaceuticals LLC, AbbVie Inc., Viatris, Boehringer Ingelheim International GmbH, GSK plc, ABL bio, Teva Pharmaceuticals Industries Ltd, Pfizer Inc., and Novartis AG are some of the major players among others.drug

Parkinson's Disease Drugs Market Leaders

  1. GlaxoSmithKline PLC

  2. Boehringer Ingelheim International GmbH

  3. Newron Pharmaceuticals SPA

  4. F. Hoffmann-La Roche Ltd

  5. AbbVie Inc.

*Disclaimer: Major Players sorted in no particular order

Parkinson's Disease Drugs Market Concentration

Parkinsons Disease Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)